Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Treatment for Latent Tuberculosis (TB) Infection: Isoniazid and Rifapentine (INH-RPT)

Information Sheet
Treatment for Latent Tuberculosis (TB) Infection: Isoniazid and Rifapentine (INH-RPT)

This fact sheet provides information regarding the 12-dose regimen for treating latent TB infection.

Author:

Minnesota Department of Health Tuberculosis Program

Audiences:

Adults, At Risk Persons, Non-U.S.-born persons, General Public, Persons with TB

Topic:

Treatment Guidelines Materials, Patient Care, TB

Country of Origin:

United States

Download PDF

Related Materials

Treatment for Latent Tuberculosis (TB) Infection: Isoniazid and Rifapentine (INH-RPT)

This handout contains information for patients that are prescribed the 3HP regimen for the treatment of latent TB infection. The 3HP regimen is a 3-month once weekly regimen of isoniazid and rifapentine. The handout includes space to record the patient's doctor/clinic contact information. 

Brochure

12-dose Isoniazid/Rifapentine Regimen for Latent TB Infection Treatment

This fact sheet provides an overview of the 12-dose regimen for treating latent TB infection.

Fact Sheet

What You Need to Know About Your Medicine for Latent Tuberculosis (TB) Infection – Isoniazid and Rifapentine

This Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

Information Sheet

Global resources for the prevention,
management, and elimination of TB.